Lymphoma Clinical Trials in Cleveland

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1384 more
2022-01-13
Jan 13, 2022
S
S0313 Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Radiation Therapy Followed By Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma - 2015
Completed
Has Results
  • Lymphoma
  • rituximab
  • +7 more
  • Anchorage, Alaska
  • +47 more
2021-12-22
Dec 22, 2021
E
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Active, not recruiting
  • Lymphoma
  • +2 more
  • rituximab
  • +3 more
  • Anchorage, Alaska
  • +417 more
2021-12-29
Dec 29, 2021
S
Safety Study of SEA-CD40 in Cancer Patients
Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +19 more
  • Intravenous (IV) SEA-CD40
  • +4 more
  • Birmingham, Alabama
  • +18 more
2021-12-10
Dec 10, 2021
N
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction
Active, not recruiting
  • Glioma
  • +49 more
  • Duarte, California
  • +11 more
2021-11-30
Nov 30, 2021
B
A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase - 2021
Completed
  • Lymphoma
  • Acute Lymphoblastic Leukemia
  • Apixaban
  • No systemic anticoagulant prophylaxis
  • Phoenix, Arizona
  • +95 more
2021-11-01
Nov 1, 2021
T
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Recruiting
  • Locally Advanced Solid Tumors
  • +3 more
  • Oral repotrectinib (TPX-0005)
  • Los Angeles, California
  • +26 more
2021-11-03
Nov 3, 2021
R
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Active, not recruiting
Has Results
  • Chemotherapeutic Agent Toxicity
  • +4 more
  • Rituximab
  • +5 more
  • Birmingham, Alabama
  • +44 more
2021-11-02
Nov 2, 2021
C
Transplant Wellness Clinic for Elderly or High Risk Patients Undergoing BMT
Recruiting
  • Stem Cell Transplant Complications
  • +3 more
  • physical therapy consult
  • +8 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
2021-11-02
Nov 2, 2021
M
TAC/MTX vs. TAC/MMF/PTCY for Prevention of Graft-versus-Host Disease and Microbiome and Immune Reconstitution Study (BMT CTN 1703/1801)
Active, not recruiting
  • Acute Leukemia
  • +3 more
  • Mobilized Peripheral Blood Stem Cell graft with Tacrolimus/Methotrexate
  • +5 more
  • Birmingham, Alabama
  • +38 more
2021-10-25
Oct 25, 2021
S
S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Newly Diagnosed Non-Hodgkin's Lymphoma
Active, not recruiting
Has Results
  • Lymphoma
  • rituximab
  • +5 more
  • Anchorage, Alaska
  • +258 more
2021-09-21
Sep 21, 2021
R
Study of Cemiplimab and REGN1979 in Patients With Lymphoma
Active, not recruiting
  • Lymphoma
  • Santa Monica, California
  • +21 more
2021-09-20
Sep 20, 2021
C
Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas
Active, not recruiting
  • Anaplastic Large Cell Lymphoma
  • +4 more
  • Laboratory Biomarker Analysis
  • Questionnaire Administration
  • Birmingham, Alabama
  • +106 more
2021-09-02
Sep 2, 2021
C
Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant
Recruiting
  • Hematopoietic and Lymphoid System Neoplasm
  • +3 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +3 more
  • Birmingham, Alabama
  • +42 more
2021-08-23
Aug 23, 2021
A
Donor Stem Cell Transplant in Treating Patients With High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Active, not recruiting
Has Results
  • Leukemia
  • Lymphoma
  • rituximab
  • +7 more
  • Duarte, California
  • +24 more
2021-08-16
Aug 16, 2021
A
Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma - 2018
Completed
Has Results
  • Lymphoma
  • Bleomycin Sulfate
  • +11 more
  • Tucson, Arizona
  • +94 more
2021-06-10
Jun 10, 2021
T
TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers
Recruiting
  • Solid Tumor
  • Lymphoma
  • Orange, California
  • +16 more
2021-04-29
Apr 29, 2021
T
A Study of TAK-981 in Participants With Relapsed/Refractory Solid Tumors or Non-Hodgkin Lymphoma (NHL)
Recruiting
  • Neoplasms
  • +2 more
  • La Jolla, California
  • +7 more
2021-03-24
Mar 24, 2021
M
Clofarabine in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment - 2021
Completed
  • Leukemia
  • +2 more
  • New York, New York
  • +2 more
2021-03-01
Mar 1, 2021
E
Bendamustine Hydrochloride and Rituximab With or Without Bortezomib Followed by Rituximab With or Without Lenalidomide in Treating Patients With High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma
Active, not recruiting
Has Results
  • Lymphoma
  • rituximab
  • +3 more
  • Greenbrae, California
  • +226 more
2021-02-02
Feb 2, 2021
S
S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma
Active, not recruiting
Has Results
  • Lymphoma
  • Nonneoplastic Condition
  • bleomycin sulfate
  • +11 more
  • Tucson, Arizona
  • +422 more
2021-01-29
Jan 29, 2021
B
Lenalidomide, Ixazomib, and Rituximab as Front-Line Therapy for High Risk Indolent B-Cell Lymphoma
Active, not recruiting
Has Results
  • B Cell Lymphoma
  • Lymphoma
  • Cleveland, Ohio
  • +1 more
2021-01-08
Jan 8, 2021
G
Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard Umbilical Cord Blood in Patients With Leukemia, Lymphoma, and Myelodysplastic Syndrome (MDS)
Active, not recruiting
  • Hematological Malignancies
  • +6 more
  • NiCord® (omidubicel)
  • Cord Blood Unit
  • Los Angeles, California
  • +51 more
2021-01-07
Jan 7, 2021
E
Rituximab and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin's Lymphoma - 2019
Completed
Has Results
  • Lymphoma
  • filgrastim
  • +8 more
  • Palo Alto, California
  • +103 more
2020-10-23
Oct 23, 2020
E
Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
Active, not recruiting
Has Results
  • Lymphoma
  • rituximab
  • Scottsdale, Arizona
  • +482 more
2020-10-23
Oct 23, 2020